Discoveries in thrombosis care for medical patients

被引:14
作者
Cohen, AT [1 ]
机构
[1] Guys Kings St Thomas Acad Dept Surg, London SE5 9PJ, England
关键词
enoxaparin; low-molecular-weight heparin; risk factor profiles; thromboprophylaxis; venous thromboembolism;
D O I
10.1055/s-2002-34081
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Medical patients represent the majority of hospitalized patients, and at least 75% of fatal pulmonary emboli occur in this group. Medical patients are at significant risk of thromboembolic disease, yet few are considered for thromboprophylaxis. Recent studies have identified the risk factor profiles in this group of patients, and a risk assessment model for medical patients has been developed. Risk stratification will help to ensure that patients receive appropriate thromboprophylaxis. It is clear that patients with severe chronic respiratory disease, congestive heart failure, and infectious disease are at high risk of symptomatic venous thromboembolism (VTE), particularly pulmonary embolism. Heparin-based prophylaxis significantly reduces the incidence of VTE. Low-molecular-weight heparin offers a safe and cost-effective alternative to unfractionated heparin in medical patients; to date, enoxaparin is the only low-molecular-weight heparin licensed for thromboprophylaxis in this indication.
引用
收藏
页码:13 / 17
页数:5
相关论文
共 15 条
[1]   THE PREVALENCE OF RISK-FACTORS FOR VENOUS THROMBOEMBOLISM AMONG HOSPITAL PATIENTS [J].
ANDERSON, FA ;
WHEELER, HB ;
GOLDBERG, RJ ;
HOSMER, DW ;
FORCIER, A .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (08) :1660-1664
[2]  
Cohen A. T., 2000, Seminars in Hematology, V37, P19, DOI 10.1016/S0037-1963(00)90096-9
[3]  
Cohen AT, 1996, HAEMOSTASIS, V26, P65
[4]   Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD [J].
Fraisse, F ;
Holzapfel, L ;
Coulaud, JM ;
Simmoneau, G ;
Bedock, B ;
Feissel, M ;
Herbecq, P ;
Pordes, R ;
Poussel, JF ;
Roux, L .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (04) :1109-1114
[5]   Prevention of venous thromboembolism [J].
Geerts, WH ;
Heit, JA ;
Clagett, GP ;
Pineo, GF ;
Colwell, CW ;
Anderson, FA ;
Wheeler, HB .
CHEST, 2001, 119 (01) :132S-175S
[6]  
HAUCH O, 1990, ACTA CHIR SCAND, V156, P747
[7]   Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke:: a randomized, double-blind study [J].
Hillbom, M ;
Erilä, T ;
Sotaniemi, K ;
Tatlisumak, T ;
Sarna, S ;
Kaste, M .
ACTA NEUROLOGICA SCANDINAVICA, 2002, 106 (02) :84-92
[8]  
Kleber FX, 1999, THROMB HAEMOSTASIS, P492
[9]  
Kleber FX, 1999, CIRCULATION, V100, P619
[10]  
Lloyd AC, 2001, J MED EC, V4, P99